12.6: Narcolepsy

Last updated
Save as PDF

Page ID: 75081

\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \) \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)\(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\) \(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\)\(\newcommand{\AA}{\unicode[.8,0]{x212B}}\)

Unlike the other sleep disorders described in this section, a person with narcolepsy cannot resist falling asleep at inopportune times. These sleep episodes are often associated with cataplexy, which is a lack of muscle tone or muscle weakness, and in some cases involves complete paralysis of the voluntary muscles. This is similar to the kind of paralysis experienced by healthy individuals during REM sleep (Burgess & Scammell, 2012; Hishikawa & Shimizu, 1995; Luppi et al., 2011). Narcoleptic episodes take on other features of REM sleep. For example, around one third of individuals diagnosed with narcolepsy experience vivid, dream-like hallucinations during narcoleptic attacks (Chokroverty, 2010).

Surprisingly, narcoleptic episodes are often triggered by states of heightened arousal or stress. The typical episode can last from a minute or two to half an hour. Once awakened from a narcoleptic attack, people report that they feel refreshed (Chokroverty, 2010). Obviously, regular narcoleptic episodes could interfere with the ability to perform one’s job or complete schoolwork, and in some situations, narcolepsy can result in significant harm and injury (e.g., driving a car or operating machinery or other potentially dangerous equipment).

Generally, narcolepsy is treated using psychomotor stimulant drugs, such as amphetamines (Mignot, 2012). These drugs promote increased levels of neural activity. Narcolepsy is associated with reduced levels of the signaling molecule hypocretin in some areas of the brain (De la Herrán-Arita & Druck- er-Colín, 2012; Han, 2012), and the traditional stimulant drugs do not have direct effects on this system. Therefore, it is quite likely that new medications that are developed to treat narcolepsy will be designed to target the hypocretin system.

There is a tremendous amount of variability among sufferers, both in terms of how symptoms of narcolepsy manifest and the effectiveness of currently available treatment options. This is illustrated by McCarty’s (2010) case study of a 50-year- old woman who sought help for the excessive sleepiness during normal waking hours that she had experienced for several years. She indicated that she had fallen asleep at inappropriate or dangerous times, including while eating, while socializing with friends, and while driving her car. During periods of emotional arousal, the woman complained that she felt some weakness in the right side of her body. Although she did not experience any dream-like hallucinations, she was diagnosed with narcolepsy as a result of sleep testing. In her case, the fact that her cataplexy was confined to the right side of her body was quite unusual. Early attempts to treat her condition with a stimulant drug alone were unsuccessful. How- ever, when a stimulant drug was used in conjunction with a popular antidepressant, her condition improved dramatically.

REFERENCES

Arnulf, I. (2012). REM sleep behavior disorder: Motor manifestations and pathophysiology. Movement Disorders, 27, 677–689. doi. org/10.1002/mds.24957

Berkowitz, C. D. (2012). Sudden infant death syndrome, sudden unexpected infant death, and apparent life-threatening events. Advances in Pediatrics, 59, 183–208. https://doi.org/10.1016/j.yapd.2012.04.011

Berry, R. B., Kryger, M. H., & Massie, C. A. (2011). A novel nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: A randomized controlled trial. Sleep, 34, 479–485. https://doi.org/10.1093/sleep/34.4.479

Bixler, E. O., Kales, A., Soldatos, C. R., Kales, J. D., & Healey, S. (1979). Prevalence of sleep disorders in the Los Angeles metropolitan area. American Journal of Psychiatry, 136, 1257–1262.

Broughton, R., Billings, R., Cartwright, R., Doucette, D., Edmeads, J., Edwardh, M., Ervin, F., Orchard, B., Hill, R., & Turrell, G. (1994). Homicidal somnambulism: A case report. Sleep, 17, 253–264. https:// doi.org/10.1093/sleep/17.3.253

Burgess, C. R., & Scammell, T. E. (2012). Narcolepsy: Neural mechanisms of sleepiness and cataplexy. Journal of Neuroscience, 32, 12305– 12311. https://doi.org/10.1523/JNEUROSCI.2630-12.2012

Cartwright, R. (2004). Sleepwalking violence: A sleep disorder, a legal dilemma, and a psychological challenge. American Journal of Psychiatry, 161, 1149–1158. https://doi.org/10.1176/appi.ajp.161.7.1149

Chokroverty, S. (2010). Overview of sleep & sleep disorders. Indian Journal of Medical Research, 131, 126–140.

CNN. (1999, June 25). ‘Sleepwalker’ convicted of murder. www. cnn.com/US/9906/25/sleepwalker.01/

De la Herrán-Arita, A. K., & Drucker-Colín, R. (2012). Models for narcolepsy with cataplexy drug discovery. Expert Opinion on Drug Discovery, 7, 155–164. https://doi.org/10.1517/17460441.2012.651454

Ferini-Strambi, L. (2011). Does idiopathic REM sleep behavior disorder (iRBD) really exist? What are the potential markers of neurodegeneration in iRBD? Sleep Medicine, 12(2 Suppl.), S43–S49. https://doi.org/10.1016/j.sleep.2011.10.010

Guilleminault, C., Kirisoglu, C., Bao, G., Arias, V., Chan, A., & Li, K. K. (2005). Adult chronic sleepwalking and its treatment based on polysomnography. Brain, 128, 1062–1069. doi.org/10.1093/ brain/awh481

Han, F. (2012). Sleepiness that cannot be overcome: Narcolepsy and cataplexy. Respirology, 17, 1157–1165. doi. org/10.1111/j.1440-1843.2012.02178.x

Henry, D., & Rosenthal, L. (2013). “Listening for his breath:” The significance of gender and partner reporting on the diagnosis, management, and treatment of obstructive sleep apnea. Social Science & Medicine, 79, 48–56. https://doi.org/10.1016/j.socscimed.2012.05.021

Hishikawa, Y., & Shimizu, T. (1995). Physiology of REM sleep, cataplexy, and sleep paralysis. Advances in Neurology, 67, 245–271.

Hossain, J. L., & Shapiro, C. M. (2002). The prevalence, cost implications, and management of sleep disorders: An overview. Sleep and Breathing, 6, 85–102. https://doi.org/10.1055/s-2002-32322

Luppi, P.-H., Clément, O., Sapin, E., Gervasoni, D., Peyron, C., Léger, L., Salvert, D., & Fort, P. (2011). The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder. Sleep Medicine Reviews, 15, 153–163. https://doi.org/10.1016/j.smrv.2010.08.002

Mage, D. T., & Donner, M. (2006). Female resistance to hypoxia: Does it explain the sex difference in mortality rates? Journal of Women’s Health, 15, 786–794. https://doi.org/10.1089/jwh.2006.15.786

Mahowald, M. W., & Schenck, C. H. (2000). Diagnosis and management of parasomnias. Clinical Cornerstone, 2, 48–54. doi. org/10.1016/S1098-3597(00)90040-1

Mahowald, M. W., Schenck, C. H., & Cramer Bornemann, M. A. (2005). Sleep-related violence. Current Neurology and Neuroscience Reports, 5, 153–158. https://doi.org/10.1007/s11910-005-0014-3

Mayo Clinic. (n.d.). Sleep terrors (night terrors): Diagnosis and treatment. www.mayoclinic.org/diseases-c...errors/basics/ treatment/con-20032552

McCarty, D. E. (2010). A case of narcolepsy with strictly unilateral cataplexy. Journal of Clinical Sleep Medicine, 15, 75–76. doi. org/10.5664/jcsm.27714

McDaid, C., Durée, K. H., Griffin, S. C., Weatherly, H. L. A., Stradling, J. R., Davies, R. J. O., Sculpher, M. J., & Westwood, M. E. (2009). A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep Medicine Reviews, 13, 427–436. https://doi.org/10.1016/j.smrv.2009.02.004

Mignot, E. J. M. (2012). A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics, 9, 739–752. doi. org/10.1007/s13311-012-0150-9

Mitchell, E. A. (2009). SIDS: Past, present and future. Acta Paediatrica, 98, 1712–1719. doi.org/10.1111/j.1651-2227.2009.01503.x

Ohayon, M. M. (1997). Prevalence of DSM-IV diagnostic criteria of insomnia: Distinguishing insomnia related to mental disorders from sleep disorders. Journal of Psychiatric Research, 31, 333–346. https://doi.org/10.1016/S0022-3956(97)00002-2

Ohayon, M. M. (2002). Epidemiology of insomnia: What we know and what we still need to learn. Sleep Medicine Reviews, 6, 97–111. https://doi.org/10.1053/smrv.2002.0186

Ohayon, M. M., & Roth, T. (2002). Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. Journal of Psychosomatic Research, 53, 547–554. doi. org/10.1016/S0022-3999(02)00443-9

Pressman, M. R. (2007). Disorders of arousal from sleep and violent behavior: The role of physical contact and proximity. Sleep, 30, 1039–1047. https://doi.org/10.1093/sleep/30.8.1039

Provini, F., Tinuper, P., Bisulli, F., & Lugaresi, E. (2011). Arousal disorders. Sleep Medicine, 12(2 Suppl.), S22–S26. doi.org/10.1016/j. sleep.2011.10.007

Restless Legs Syndrome Foundation. (n.d.). Restless legs syndrome: Causes, diagnosis, and treatment for the patient living with restless legs syndrome (RSL) [Brochure]. www.rls.org/ understanding-rls

Roth, T. (2007). Insomnia: Definition, prevalence, etiology, and consequences. Journal of Clinical Sleep Medicine, 3(5 Suppl.), S7–S10. https://doi.org/10.5664/jcsm.26929

Sánchez-de-la-Torre, M., Campos-Rodriguez, F., & Barbé, F. (2012). Obstructive sleep apnoea and cardiovascular disease. The Lancet Respiratory Medicine, 1, 31–72. doi.org/10.1016/ S2213-2600(12)70051-6

Savard, J., Simard, S., Ivers, H., & Morin, C. M. (2005). Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. Journal of Clinical Oncology, 23, 6083–6096. doi.org/10.1200/ JCO.2005.09.548

Task Force on Sudden Infant Death Syndrome. (2011). SIDS and other sleep-related infant deaths: Expansion of recommendations for a safe infant sleeping environment. Pediatrics, 128, 1030–1039. https:// doi.org/10.1542/peds.2011-2285

Thach, B. T. (2005). The role of respiratory control disorders in SIDS. Respiratory Physiology & Neurobiology, 149, 343–353. doi. org/10.1016/j.resp.2005.06.011

White, D. P. (2005). Pathogenesis of obstructive and central sleep apnea. American Journal of Respiratory and Critical Care Medicine, 172, 1363–1370. https://doi.org/10.1164/rccm.200412-1631SO

Williams, J., Roth, A., Vatthauer, K., & McCrae, C. S. (2013). Cognitive behavioral treatment of insomnia. Chest, 143, 554–565. doi. org/10.1378/chest.12-0731

Zanigni, S., Calandra-Buonaura, G., Grimaldi, D., & Cortelli, P. (2011). REM behaviour disorder and neurodegenerative diseases. Sleep Medicine, 12(2 Suppl.), S54–S58. https://doi.org/10.1016/j.sleep.2011.10.012